4Moving Biotech Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$14.1M
- Investors
-
4
4Moving Biotech General Information
Description
Operator of a biopharmaceutical research firm intended to develop therapies for osteoarthritis patients. The company uses GLP-1 analogs to target low-grade inflammation and integrates advanced artificial intelligence with real-world data to accelerate clinical trial design, enabling the restoration of mobility and improving quality of life.
Contact Information
Website
www.4movingbiotech.comCorporate Office
- 1 Rue Du Professeur Calmette
- 59800 Lille
- France
Corporate Office
- 1 Rue Du Professeur Calmette
- 59800 Lille
- France
4Moving Biotech Timeline
4Moving Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 10-Feb-2026 | $14.1M | Completed | Generating Revenue | ||
| 3. Grant | 08-Apr-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 29-Apr-2021 | $2.39M | $2.39M | Completed | Generating Revenue | |
| 1. Spin-Off | 01-Jan-2020 | Completed | Generating Revenue |
4Moving Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| A Class | 40,569 | $1.193700 | $16.77 | $16.77 | 1x | $16.77 | 6.51% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
4Moving Biotech Patents
4Moving Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025257419-A1 | Glp-1 receptor agonist compounds for treating a proliferative synovial disorder | Pending | 13-Jun-2024 | ||
| WO-2025219601-A1 | New glp-1 receptor agonists for the treatment of joint diseases | Pending | 18-Apr-2024 | ||
| AU-2022300340-A1 | Pharmaceutical compositions comprising glp-1r agonists | Pending | 23-Jun-2021 | ||
| CA-3223710-A1 | Pharmaceutical compositions comprising glp-1r agonists | Pending | 23-Jun-2021 | ||
| EP-4108252-A1 | Pharmaceutical compositions comprising glp-1r agonists | Inactive | 23-Jun-2021 | A61K38/26 |
4Moving Biotech Signals
4Moving Biotech Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| France 2030 | Government | |||
| 4P-Pharma | PE-Backed Company | Minority | ||
| Bpifrance | Sovereign Wealth Fund | |||
| SATT Lutech | Accelerator/Incubator | Minority |
4Moving Biotech FAQs
-
When was 4Moving Biotech founded?
4Moving Biotech was founded in 2020.
-
Where is 4Moving Biotech headquartered?
4Moving Biotech is headquartered in Lille, France.
-
What is the size of 4Moving Biotech?
4Moving Biotech has 8 total employees.
-
What industry is 4Moving Biotech in?
4Moving Biotech’s primary industry is Biotechnology.
-
Is 4Moving Biotech a private or public company?
4Moving Biotech is a Private company.
-
What is 4Moving Biotech’s current revenue?
The current revenue for 4Moving Biotech is .
-
How much funding has 4Moving Biotech raised over time?
4Moving Biotech has raised $16.5M.
-
Who are 4Moving Biotech’s investors?
France 2030, 4P-Pharma, Bpifrance, and SATT Lutech have invested in 4Moving Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process